On Air Now

Current Show

Sportstalk   4:00 PM - 5:00 PM

SportsTalk with Joe and Pat

Show Info »

Upcoming Shows

Program Schedule »

Tune in to Listen

650 AM Hibbing, Minnesota

Weather

Current Conditions(Hibbing,MN 55746)

More Weather »
34° Feels Like: 25°
Wind: NW 12 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Rain/Snow 32°

Tomorrow

Rain/Snow 45°

Fri Night

Partly Cloudy 27°

Alerts

New formulation of Roche's Herceptin wins EU approval

ZURICH (Reuters) - Swiss drugmaker Roche said on Monday the European Commission had approved a new formulation of its breast cancer drug Herceptin which allows the medicine to be administered more quickly.

Roche said it had won approval for a new injectable version of Herceptin which cuts down treatment time to just two to five minutes. It currently takes between 30 to 90 minutes to administer the drug intravenously.

Herceptin is used as a treatment for around a quarter of breast cancer patients who have tumors that generate a protein called HER2, which tends to make their disease more aggressive.

The drug, which goes off patent next year, is Roche's third-biggest seller and notched up global revenues of 3.08 billion Swiss francs ($3.30 billion) in the first half of the year.

(Reporting by Caroline Copley)

Comments